Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cd4+ Lymphocyte Deficiency”

164 trials

Showing 20 of 164 results

Not applicableStudy completedNCT02934022
What this trial is testing

Adding Maraviroc to the HAART Regimen of Well Controlled HIV-infected Patients

Who this might be right for
HIV Infection
Southern California Institute for Research and Education 25
Not applicableStudy completedNCT00000883
What this trial is testing

Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 636
Early research (Phase 1)Study completedNCT00000667
What this trial is testing

A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ Cells

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Not applicableStudy completedNCT01048372
What this trial is testing

Observational Study of Blood Treated With Cytolin

Who this might be right for
HIV Infections
CytoDyn, Inc. 20
Not applicableStudy completedNCT00025922
What this trial is testing

Influenza Vaccine in HIV Infection: Immune Response and Effect on Viral Load

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 240
Post-approval studies (Phase 4)Study completedNCT00875368
What this trial is testing

Maraviroc Immune Recovery Study

Who this might be right for
HIV Infections
S.F.L. van Lelyveld 85
Testing effectiveness (Phase 2)Study completedNCT00002435
What this trial is testing

Thymic Humoral Factor (THF Gamma 2) in HIV-Infected Patients

Who this might be right for
HIV Infections
Pharmacia
Not applicableStudy completedNCT00002236
What this trial is testing

Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients

Who this might be right for
HIV Infections
Pharmacia and Upjohn 32
Testing effectiveness (Phase 2)Ended earlyNCT00839436
What this trial is testing

Interleukin-7 (CYT107) Treatment of Idiopathic CD4 Lymphocytopenia: Expansion of CD4 T Cells (ICICLE)

Who this might be right for
Idiopathic CD4+ T-Lymphocytopenia
National Institute of Allergy and Infectious Diseases (NIAID) 21
Early research (Phase 1)Study completedNCT00000728
What this trial is testing

Phase I Trial of the Combination of Zidovudine and Recombinant Interleukin-2 in Patients With Persistent Generalized Lymphadenopathy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Large-scale testing (Phase 3)Study completedNCT00002359
What this trial is testing

A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega

Who this might be right for
HIV Infections
The Immune Response Corporation 3,000
Testing effectiveness (Phase 2)Study completedNCT00011037
What this trial is testing

ALVAC-HIV vCP1452 Alone and Combined With MN rgp120

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 160
Not applicableStudy completedNCT00100581
What this trial is testing

Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 2
Testing effectiveness (Phase 2)Study completedNCT00011011
What this trial is testing

Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 94
Large-scale testing (Phase 3)Study completedNCT00028327
What this trial is testing

Potent Antiviral Therapy for Critically Ill HIV Infected Patients Admitted to Intensive Care

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 250
Not applicableStudy completedNCT00000907
What this trial is testing

Examine the Effects of Stopping Preventive Therapy for Disseminated Mycobacterium Avium Complex (DMAC) in HIV-Positive Patients

Who this might be right for
Mycobacterium Avium-Intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 50
Large-scale testing (Phase 3)Study completedNCT00000841
What this trial is testing

Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,750
Early research (Phase 1)UnknownNCT00005120
What this trial is testing

The Safety and Effectiveness of (+)-Calanolide A in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Sarawak MediChem Pharmaceuticals 16
Not applicableStudy completedNCT00000932
What this trial is testing

The Long-Term Outcomes of HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 3,669
Large-scale testing (Phase 3)UnknownNCT01289106
What this trial is testing

Modified Dose and Schedule of Recombinant Hepatitis B Vaccination in HIV-infected Adult Subjects

Who this might be right for
HIV Infection
Chiang Mai University 132
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation